Investing Ideas
/
Global Pharmaceuticals & Biotech Can They Turn the Tide

Header cover image

Global Pharmaceuticals & Biotech Can They Turn the Tide

UPDATED May 23, 2024

Annually loss-making mid-caps and large-caps with sound financial health.

62 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	KDNY Chinook Therapeutics	US$40.39	0.3%	95.7%	US$2.9b	US$40.09	PS495.8x	E22.6%	n/a
	PCVX Vaxcyte	US$69.27	-8.2%	42.6%	US$7.8b	US$103.14	PB3.8x	E1.3%	n/a
	NTLA Intellia Therapeutics	US$24.88	-4.9%	-36.6%	US$2.5b	US$70.26	PS45.6x	E33.1%	n/a
	ARWR Arrowhead Pharmaceuticals	US$24.67	-1.3%	-26.5%	US$3.1b	US$53.77	PS86.4x	E34.4%	n/a
	APGE Apogee Therapeutics	US$46.04	-14.3%	n/a	US$2.8b	US$84.83	PB3.4x	E-24.5%	n/a
	TWST Twist Bioscience	US$41.36	-11.1%	176.5%	US$2.5b	US$43.38	PS8.7x	E20.5%	n/a
	TXG 10x Genomics	US$22.95	-10.3%	-55.2%	US$2.9b	US$41.14	PS4.4x	E63.2%	n/a
	KYMR Kymera Therapeutics	US$34.24	-3.8%	18.2%	US$2.2b	US$50.80	PS26.5x	E-4.9%	n/a
	CRSP CRISPR Therapeutics	US$55.73	0.1%	-12.7%	US$4.8b	US$86.57	PS17.4x	E42.7%	n/a
	MLTX MoonLake Immunotherapeutics	US$39.96	-2.2%	40.0%	US$2.5b	US$73.31	PB4.6x	E2.9%	n/a
	AZTA Azenta	US$50.27	-2.1%	21.1%	US$2.8b	US$62.60	PS4.2x	E83.8%	0%
	DICE DICE Therapeutics	US$47.55	0.2%	131.2%	US$2.3b	US$48.00	PB4.4x	E-22.3%	n/a
	CERE Cerevel Therapeutics Holdings	US$41.63	-1.7%	27.8%	US$7.6b	US$44.78	PB13.4x	E16.0%	n/a
	MRVI Maravai LifeSciences Holdings	US$10.78	-2.9%	-18.5%	US$2.8b	US$10.42	PS5.2x	E111.0%	n/a

Page 3 of 3